Australian Trends in ecstasy and related drug markets 2005: Findings from the Party Drugs Initiative (PDI)

This work is copyright. You may download, display, print and reproduce this material in unaltered form only (retaining this notice) for your personal, non-commercial use or use within your organisation. All other rights are reserved. Requests and enquiries concerning reproduction and rights should be addressed to the information manager,

[1]  K. Jansen.  Ketamine--can chronic use impair memory? , 1990, The International journal of the addictions.

[2]  A. Forsyth,et al.  Places and patterns of drug use in the Scottish dance scene. , 1996, Addiction.

[3]  S. McCabe,et al.  Ecstasy use among college undergraduates: gender, race and sexual identity. , 2003, Journal of substance abuse treatment.

[4]  H. Wechsler,et al.  Increasing MDMA use among college students: results of a national survey. , 2002, The Journal of adolescent health : official publication of the Society for Adolescent Medicine.

[5]  D. Caldicott,et al.  Underground pill testing, down under. , 2005, Forensic science international.

[6]  R. Laranjeira,et al.  Validity and reliability of the Severity of Dependence Scale (SDS) in a Brazilian sample of drug users. , 2000, Drug and Alcohol Review.

[7]  H. Curran,et al.  Mood and cognitive effects of +/-3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. , 1997, Addiction.

[8]  F. F. Yoong,et al.  Gamma‐hydroxybutyric acid: an emerging recreational drug , 1998, Anaesthesia.

[9]  S. Allsop,et al.  Physical and mental health problems in amphetamine users from metropolitan Adelaide, Australia. , 1998, Drug and alcohol review.

[10]  W. Loxley,et al.  BINGEING ON PSYCHOSTIMULANTS IN AUSTRALIA: DO WE KNOW WHAT IT MEANS (AND DOES IT MATTER)? , 1996 .

[11]  Stephen W. Smith,et al.  Adverse events, including death, associated with the use of 1,4-butanediol. , 2001, The New England journal of medicine.

[12]  R. Bruno,et al.  Tasmanian Drug Trends 2015. Findings from the Illicit Drug Reporting System (IDRS) , 2000 .

[13]  S. Lenton,et al.  Polydrug use at raves by a Western Australian sample. , 1997, Drug and alcohol review.

[14]  W. Hall,et al.  Amphetamine-related harms and treatment preferences of regular amphetamine users in Sydney, Australia. , 1997, Drug and alcohol dependence.

[15]  Louisa Degenhardt,et al.  The emergence of potent forms of methamphetamine in Sydney, Australia: a case study of the IDRS as a strategic early warning system. , 2002, Drug and alcohol review.

[16]  J. Fountain,et al.  Adverse effects of stimulant drugs in a community sample of drug users. , 1997, Drug and alcohol dependence.

[17]  M. Vickers.  GAMMAHYDROXYBUTYRIC ACID , 1969, International anesthesiology clinics.

[18]  L. Topp,et al.  Sexual behaviour of ecstasy users in Sydney, Australia , 1999 .

[19]  R. Clark,et al.  Coma and respiratory depression following the ingestion of GHB and its precursors: three cases. , 2000, The Journal of emergency medicine.

[20]  A. Hunter,et al.  An evaluation of gamma-hydroxybutyric acid in paediatric practice. , 1971, British journal of anaesthesia.

[21]  R. Bruno,et al.  Tasmanian trends in ecstasy and related drug markets 2005: findings from the Party Drug Initiative (PDI) , 2006 .

[22]  M. Farrell,et al.  Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region. , 2002, Addiction.

[23]  J. Bostwick,et al.  Ketamine dependence in anesthesia providers. , 1999, Psychosomatics.

[24]  G. Rumbold,et al.  Ambulance attendance at heroin overdose in Melbourne: the establishment of a database of Ambulance Service records , 2000 .

[25]  Andrew C. Parrott,et al.  Ecstasy (MDMA) in Recreational Users: Self‐Reported Psychological and Physiological Effects , 1997 .

[26]  Raimondo Bruno,et al.  Australian Drug Trends 2004: Findings from the Illicit Drug Reporting System (IDRS) , 2006 .

[27]  Gerard J Fitzsimmons,et al.  From the Australian Institute of Health and Welfare , 2014, Communicable diseases intelligence quarterly report.

[28]  K. Kosaka,et al.  Methamphetamine in Japan: the consequences of methamphetamine abuse as a function of route of administration. , 2002, Addiction.

[29]  J. Najman,et al.  Australian Drug Trends , 2001 .

[30]  K. Nicholson,et al.  GHB: a new and novel drug of abuse. , 2001, Drug and alcohol dependence.

[31]  N. Solowij,et al.  Ecstasy use in Australia: patterns of use and associated harm. , 1999, Drug and alcohol dependence.

[32]  J. Arditti,et al.  [Ketamine--dreams and realities]. , 2002, Acta clinica Belgica.

[33]  T. Buchanan,et al.  Ecstasy/MDMA attributed problems reported by novice, moderate and heavy recreational users , 2002, Human psychopharmacology.

[34]  M. Mamelak,et al.  Gammahydroxybutyrate: An endogenous regulator of energy metabolism , 1989, Neuroscience & Biobehavioral Reviews.

[35]  L. Degenhardt,et al.  GHB use among Australians: characteristics, use patterns and associated harm. , 2002, Drug and alcohol dependence.

[36]  W. Hall,et al.  Recreational MDMA use in Sydney: a profile of 'Ecstacy' users and their experiences with the drug. , 1992, British journal of addiction.

[37]  M. Longo,et al.  Adapting the IDRS methodology to monitor trends in party drug markets , 2002 .

[38]  L. Degenhardt,et al.  Patterns of ecstasy use in Australia: findings from a national household survey. , 2004, Addiction.

[39]  J. Mcmanus,et al.  Severe gamma-hydroxybutyrate withdrawal: a case report and literature review. , 2000, The Journal of emergency medicine.

[40]  P. Biernacki,et al.  Snowball Sampling: Problems and Techniques of Chain Referral Sampling , 1981 .

[41]  W. Hall,et al.  Transitions between routes of administration of regular amphetamine users. , 1994, Addiction.

[42]  J. Duchin,et al.  Sharing of drug preparation equipment as a risk factor for hepatitis C. , 2001, American journal of public health.

[43]  Role of the National Centre in HIV Epidemiology and Clinical Research in surveillance for HIV/ AIDS, viral hepatitis and sexually transmissible infections in Australia. , 2004, Communicable diseases intelligence quarterly report.

[44]  R. Byard,et al.  Fatalities associated with the use of gamma-hydroxybutyrate and its analogues in Australasia. , 2004, The Medical journal of Australia.

[45]  Howard B. Lee,et al.  Foundations of Behavioral Research , 1973 .

[46]  D. Kavanagh,et al.  Review of diagnostic screening instruments for alcohol and other drug use and other psychiatric disorders , 2002 .

[47]  R. Mattick,et al.  Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. , 1997, Addiction.

[48]  W. Ling,et al.  Sexual HIV risk among gay and bisexual male methamphetamine abusers. , 1996, Journal of substance abuse treatment.

[49]  C. Breen,et al.  NSW Party Drug Trends 2001 Findings of the Illicit Drug Reporting System ( IDRS ) Party Drugs Module , 2004 .

[50]  M. Barratt,et al.  A survey of regular ecstasy users' knowledge and practices around determining pill content and purity: Implications for policy and practice , 2006 .

[51]  B Powis,et al.  The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. , 1995, Addiction.

[52]  Mack Rb.  Love potion number 8 1/2. Gamma-hydroxybutyrate poisoning. , 1993 .

[53]  L. Degenhardt,et al.  The prevalence and correlates of gamma-hydroxybutyrate (GHB) overdose among Australian users. , 2003, Addiction.

[54]  L. Degenhardt,et al.  ‘Crystal meth’ use among polydrug users in Sydney's dance party subculture: characteristics, use patterns and associated harms , 2003 .

[55]  J. Copeland,et al.  Patterns of use and harms associated with non-medical ketamine use. , 2003, Drug and alcohol dependence.

[56]  J. Gill,et al.  Ketamine in non-hospital and hospital deaths in New York City. , 2000, Journal of forensic sciences.

[57]  K. Miotto,et al.  Gamma Hydroxybutyrate (GHB) and Gamma Butyrolactone (GBL) Withdrawal: Five Case Studies , 2001, Journal of psychoactive drugs.

[58]  H. Klee.  Amphetamine Misuse: International Perspectives on Current Trends , 1997 .

[59]  R. Byard,et al.  Fatalities associated with the use of γ-hydroxybutyrate and its analogues in Australasia , 2004 .

[60]  A. Richardson,et al.  Increasing popularity of injection as the route of administration of amphetamine in Edinburgh. , 1997, Drug and alcohol dependence.

[61]  E. Kelly,et al.  A review of drug use and driving: epidemiology, impairment, risk factors and risk perceptions. , 2004, Drug and alcohol review.

[62]  A. Parrott,et al.  Ecstasy (MDMA) effects upon mood and cognition: before, during and after a Saturday night dance , 1998, Psychopharmacology.

[63]  G. Galloway,et al.  Gamma-hydroxybutyrate: an emerging drug of abuse that causes physical dependence. , 1997, Addiction.

[64]  W. Hall,et al.  Amphetamine use among young adults in Sydney, Australia , 1993 .

[65]  D. Shewan,et al.  Illicit use of ketamine in Scotland. , 1996, Journal of psychoactive drugs.

[66]  L. Degenhardt,et al.  Changes in patterns of drug injection concurrent with a sustained reduction in the availability of heroin in Australia. , 2003, Drug and alcohol dependence.

[67]  M. Morgan,et al.  Ecstasy (MDMA): a review of its possible persistent psychological effects , 2000, Psychopharmacology.

[68]  Paul Griffiths,et al.  The monitoring of drug trends in Australia. , 2003, Drug and alcohol review.